10-Jul-2014 - BioFluidix GmbH

cytena wins at Germany’s largest business plan competition

BioFluidix has joined forces with cytena GmbH to develop single cell printing technology for cell research and professional diagnostics. Together with researchers from the University of Freiburg, BioFluidix has founded cytena GmbH in June 2014. BioFluidix supports the cytena team to bring its unique drop-on-demand single cell printing technology to researchers and health care professionals. The high commercial and scientific potential of cytena’s technology was well received and highly appreciated by a jury of researchers, business professionals, pharma executives, entrepreneurs, policy makers and venture capitalists.

Therefore, the jury has awarded cytena the third price of the Science for Life Venture Cup 2014. The price was handed over in the premises of the Deutsche Bundesbank in Frankfurt by the minister for economic affairs of the state Hesse Tarek Al-Wazir and the General Manager, Research & Development at Sanofi-Aventis Deutschland GmbH Prof. Dr. Jochen Maas.

The CEO of cytena Jonas Schöndube says “We are happy to be a winner at the 2014 Science4Life Venture Cup! The support of BioFluidix and their unique dispensing technology has been crucial in our prototype development and will continue to help us making single cell handling easier and more cost efficient.” 

Facts, background information, dossiers
  • BioFluidix
  • Science4Life
  • cytena
  • Universität Freiburg
  • single cell printing
More about BioFluidix
  • News

    BioFluidix wins STEP award

    Increasing the speed, safety and cost efficiency of sample analysis: BioFluidix wins the process-category price at the 2015 STEP Award with its PipeJet Tip pipetting technology. Once per year, Infraserv Höchst KG and the F.A.Z. – Institute honor innovative and strongly growing companies of ... more

  • Videos

    Nanodispenser Workstation - As versatile as your requirements! - For laboratory and industry

    With the BioSpot Nanodispenser Workstation, we offer you a customized solution for your dosing- and dispensing tasks. Configure the BioSpot so that it fits your requirements in every respect. Based on the PipeJet Nanodispensing-Technology you can easily and efficiently solve your dispensing ... more

  • Companies

    BioFluidix GmbH

    BioFluidix GmbH is a micro technology company focused on low volume liquid handling. Our academic background combined with a long-standing expertise in working with liquid droplets, jets and sprays in the picoliter to nanoliter range inspired our unique product portfolio which comprises har ... more

More about cytena
  • News

    Cytena GmbH to be acquired by CELLINK

    The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros. Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a st ... more

    Cytena Founds Subsidiary in Taiwan

    Cytena is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development.  "With the ... more

    Molecular Devices and life science start-up cytena expand their partnership

    Molecular Devices, LLC announced an expansion in its partnership with cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ Series in North America. Building on their success of the CloneSelect™ Single-Cell Printer™ SCP™ system, the new family evolves both the ease of use for image-ba ... more

  • Companies

    cytena GmbH

    cytena GmbH is a spin-off company of the University of Freiburg. The team provides a single-cell printer for isolation of single living cells. The single-cell printer is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate, ... more

More about Uni Freiburg
  • News

    New insights into molecular mechanisms relevant for drug development

    Molecular dynamics simulations (MD) have become an ubiquitous tool in modern life sciences. In these simulations, the interactions between atoms and molecules and their resulting spatial movements are iteratively calculated and analyzed. Scientists are currently trying to gain access to bio ... more

    Programming with the Light Switch

    In the development of autonomous systems and materials, self-assembling molecular structures controlled by chemical reaction networks are increasingly important. However, there is a lack of simple external mechanisms that ensure that the components of these reaction networks can be activate ... more

    Coronavirus data analysis

    Dr. Wolfgang Maier and Dr. Björn Grüning from the University of Freiburg, together with researchers from universities in Belgium, Australia and the USA, have reviewed the previously available data on sequences of the novel coronavirus and published their analyses on the open source platform ... more